It all comes down to due diligence. OWCP has b
Post# of 15624
(Total Views: 415)
Posted On: 03/06/2017 1:17:47 PM
It all comes down to due diligence.
OWCP has been careful, calculated and strategic in all their moves and it shows in the 8Ks. They ink a deal with a manufacturer/distributor where OWCP is paid $300,000, and OWCP takes that money to pay for final IRB clinical trials.
I was looking at another MJ stock, pre-revenue, that's trading in the .90 range. Wow, they had a lease for about $2,500 a month for a grow area in NV and what to they do? Drop $100K to buy the place. Instead of keeping that capital for growth, they pre-paid their rent for two years. Genius. That's the hallmark of OTC Stinky Pinkies. The owners pay $$$ for top real estate, and pay themselves $$$ too. Then, when revenues don't hit their rosy expectations, they lower their pay and find a cheaper office space, all the while congratulating themselves for "drastic cost cutting". Total. F*cking. Joke.
I'm about to sell stock in one of my other MJ growers, and was looking at putting it into a NASDAQ MMJ company based in CT. Pre-revenue company, let's see how much the CEO is paying himself: $750,000. Wow, f*cking genius. They'll have to issue more stock soon to they can actually pay for the next FDA trials and for the management team's ski houses.
And that takes me back to OWCP, where management has been paying themselves a very modest $12,000 a year because they know they will be rewarded for their hard work through their stock holdings. As stockholders, we are in the same boat they are. If they get rich, we get rich. I like that a lot and I'll be holding my OWCP stock for years to come.
(Originally posted 1/26/17)
OWCP has been careful, calculated and strategic in all their moves and it shows in the 8Ks. They ink a deal with a manufacturer/distributor where OWCP is paid $300,000, and OWCP takes that money to pay for final IRB clinical trials.
I was looking at another MJ stock, pre-revenue, that's trading in the .90 range. Wow, they had a lease for about $2,500 a month for a grow area in NV and what to they do? Drop $100K to buy the place. Instead of keeping that capital for growth, they pre-paid their rent for two years. Genius. That's the hallmark of OTC Stinky Pinkies. The owners pay $$$ for top real estate, and pay themselves $$$ too. Then, when revenues don't hit their rosy expectations, they lower their pay and find a cheaper office space, all the while congratulating themselves for "drastic cost cutting". Total. F*cking. Joke.
I'm about to sell stock in one of my other MJ growers, and was looking at putting it into a NASDAQ MMJ company based in CT. Pre-revenue company, let's see how much the CEO is paying himself: $750,000. Wow, f*cking genius. They'll have to issue more stock soon to they can actually pay for the next FDA trials and for the management team's ski houses.
And that takes me back to OWCP, where management has been paying themselves a very modest $12,000 a year because they know they will be rewarded for their hard work through their stock holdings. As stockholders, we are in the same boat they are. If they get rich, we get rich. I like that a lot and I'll be holding my OWCP stock for years to come.
(Originally posted 1/26/17)
(4)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼